๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Concave Supra-arch Branched Stent-Graft System for Endovascular Treatment of Aortic Arch Diseases
NCT06520774Aortic Arch Aneurysm, Penetrating Aortic Ulcer
Lifetech Scientific (Shenzhen) Co., Ltd.
Not applicable
103
Beijing, Changsha, Chengdu, Fuzhou, Hanzhou, Kunming, Nanjing, Shanghai
2024-05-30
Recruiting
Pembrolizumab Plus Bevacizumab and Chemotherapy for ALK-rearranged NSCLC With Persistent 5'ALK
NCT05266846ALK Gene Mutation, Lung Adenocarcinoma, Immunotherapy
Hunan Province Tumor Hospital
Phase 2
78
Changsha
2024-05-29
Recruiting
A Global Phase 3 Study of Orelabrutinib+BR Vs.BR in Pts with TN MCL
NCT06363994Mantle Cell Lymphoma
InnoCare Pharma Inc.
Phase 3
476
Beijing, Bengbu, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Dalian
2024-05-29
Recruiting
Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases
NCT06428188Autoimmune Diseases, Systemic Lupus Erythematosus, Systemic Lupus Erythematosus Acute, Sjogren's Syndrome
Essen Biotech
Phase 1/2
60
Beijing
2024-05-29
Recruiting
Diagnostic Accuracy of EBV C Promoter Methylation Kit in Nasopharyngeal Carcinoma
NCT06445088Nasopharyngeal Carcinoma
Sun Yat-sen University
Observational
908
Fuzhou, Guangzhou, Zhongshan, Nanning, Wuzhou
2024-05-29
Recruiting
SHR-A1904 Combinations in CLDN18.2-Positive Advanced Solid Tumor
NCT06350006CLDN18.2-positive Advanced Solid Tumor
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 1
924
Guangzhou
2024-05-29
Active, closed
A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)
NCT06360354Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers
Amgen
Phase 1
120
Fuzhou, Guangzhou, Harbin, Zhengzhou, Wuhan, Changchun
2024-05-29
Recruiting
A Study of GC203 TIL in Advanced Malignant Solid Tumors
NCT06375187Solid Tumor, Gynecologic Cancer, Breast Cancer, Gastrointestinal Cancer
Shanghai Juncell Therapeutics
Phase 1
18
Shanghai
2024-05-29
Recruiting
Effects of Intraoperative Targeted Temperature Management on Incidence of Postoperative Delirium and Long-term Survival
NCT06256354Cancer Surgery, Intraoperative Hypothermia, Targeted Temperature Management, Postoperative Delirium
Peking University First Hospital
Not applicable
3,992
Chizhou, Hefei, Maโ€™anshan, Beijing, Chongqing, Shenzhen, Shijiazhuang, Harbin
2024-05-29
Recruiting
Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia
NCT06366789AML With Gene Mutations
Lomond Therapeutics Holdings, Inc.
Phase 1
150
2024-05-29
Recruiting
The Safety and Effectiveness of Steep Pulse Therapy System for the Ablation of Benign Prostatic Hyperplasia
NCT06867315Benign Prostatic Hyperplasia
First Affiliated Hospital of Zhejiang University
Not applicable
10
Hangzhou
2024-05-29
Recruiting
A Study of BL-B01D1 + PD-1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
NCT06405425Urothelial Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
52
Shanghai
2024-05-29
Recruiting
AI-Enhanced Optimization of Acute Levodopa Challenge Test
NCT06949865Vascular Parkinsonism, Drug-induced Parkinsonism, Corticobasal Degeneration (CBD), Parkinson Disease (PD)
Beijing Tiantan Hospital
Observational
2,000
Beijing
2024-05-28
Recruiting
Expressions of Ezrin and Pip5k1ฮฑ Proteins in Airway Smooth Muscle of Asthmatic Patients
NCT06427018Asthma, Protein
Lei-Miao Yin
Observational
120
Shanghai
2024-05-28
Recruiting
A Study of HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous Non-Small Cell Lung Cancer
NCT06417008Non-Squamous Non-Small Cell Lung Cancer
Hansoh BioMedical R&D Company
Phase 2/3
1,080
Tianjin, Hangzhou
2024-05-28
Recruiting
Intratumoral CAN2109 in Subjects With Solid Tumors
NCT06332430Solid Tumor, Lymphoma
Canwell Biotech Limited
Phase 1
27
Guangzhou
2024-05-28
Recruiting
Linperlisib Combined With Immunochemotherapy in Relapsed/Refractory LBCL
NCT06489808Relapsed/Refractory Large B-Cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
89
Tianjin
2024-05-28
Recruiting
A Clinical Study of SPH7854 Granules in Healthy Subjects.
NCT06483373Inflammatory Bowel Disease
Shanghai Pharmaceuticals Holding Co., Ltd
Phase EARLY_PHASE1
111
Chengdu
2024-05-28
By invitation
A Trial of AK104 or AK112 in Combination With Axitinib in Patients With Metastatic Mucosal Melanoma
NCT06424626Melanoma, Mucosal Melanoma, Metastatic Melanoma
Peking University Cancer Hospital & Institute
Phase 1
60
Beijing
2024-05-28
Recruiting
Sulfamethoxazole Prophylaxis Duration After Renal Transplantation
NCT07231770Fever, Chest Tightness
Anhui Provincial Hospital
Not applicable
450
Hefei
2024-05-28
Recruiting
PET Imaging of 68Ga-Her2-affibody in Tumors with High Her2 Expression
NCT06289517Neoplasms
Peking University First Hospital
Not applicable
30
Beijing
2024-05-28
Recruiting
The Liquid Embolic Agent for the Treatment of Brain Arteriovenous Malformation
NCT07314047Brain Arteriovenous Malformation, Arteriovenous Fistula
MicroPort NeuroTech Co., Ltd.
Not applicable
116
Shanghai
2024-05-28
Recruiting
Evaluate the Efficacy and Safety of Radiotherapy Combined With Ripretinib in the Treatment of Unresectable Advanced GIST
NCT06507683Gastrointestinal Stromal Tumors
First Affiliated Hospital of Chongqing Medical University
Not applicable
32
Chongqing
2024-05-28
Active, closed
A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
NCT06470438Lymphoma, Non-Hodgkin, Refractory B-Cell NHL, Relapsed B-cell NHL
Janssen Research & Development, LLC
Phase 1
58
Beijing, Guangzhou, Hangzhou, Shanghai, Tianjin
2024-05-28
Recruiting
Treatment of Vasospasm of Aneurysmal Subarachnoid Hemorrhage With Intrathecal Nicardipine - FAST-IT Trial
NCT06329635Aneurysmal Subarachnoid Hemorrhage, Vasospasm
The Affiliated Hospital Of Guizhou Medical University
Not applicable
396
Hefei, Beijing, Chongqing, Guangzhou, Shenzhen, Nanning, Guiyang, Kaili
2024-05-27
Recruiting
A Clinical Study of HMPL-506 in Patients With Hematological Malignancies
NCT06387082Hematological Malignancies
Hutchmed
Phase 1
132
Changsha, Chongqing, Fuzhou, Guangzhou, Guiyang, Hangzhou, Hefei, Jinan
2024-05-27
Not yet open
The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases
NCT06420154Systemic Lupus Erythematosus (SLE), Sjogren's Syndrome, Systemic Sclerosis, Inflammatory Myopathy
First Affiliated Hospital of Wenzhou Medical University
Phase EARLY_PHASE1
9
Wenzhou
2024-05-27
Recruiting
CIK Cell Therapy for Relapsed or Refractory Acute B-Lymphoblastic Leukemia: Prognostic Impact on Patients With Early CAR-T Cell Dysfunction
NCT06389305B-cell Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoid Leukemia
Beijing GoBroad Hospital
Not applicable
213
Beijing
2024-05-27
Recruiting
A Trial of SHR-A2102 With or Without Antitumor Therapy in Advanced Solid Tumors
NCT06417554Advanced Solid Tumors
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 1/2
80
Beijing
2024-05-27
Recruiting
A Study of Safety and Efficiency of AND017 in Patients With ฮฒ-thalassemia
NCT06302491ฮฒ -Thalassemia
Kind Pharmaceuticals LLC
Phase 2
64
Guangzhou, Maoming, Liuzhou, Nanning, Haikou
2024-05-27
Recruiting
Prospective Clinical Trial for Children With TCRฮฑฮฒ Depleted vs Traditional Haplo Identicle HSCT
NCT06423131Graft-Versus-Host Disease, Hematopoietic Stem Cell Transplantation, Child, Only, Haploidentical Hematopoietic Stem Cell Transplantation
Sijia Gu
Not applicable
110
Shanghai
2024-05-26
Recruiting
Linperlisib Combined With Chidamide in Patients With PTCL
NCT06421948Peripheral T-cell Lymphoma
Yanyan Liu
Phase 1/2
134
Zhengzhou, Wuhan, Changsha, Chengdu, Tianjin, Hangzhou
2024-05-25
Recruiting
Surufatinib Combined With Carboplatin/Paclitaxel and Surufatinib Combined With Olaparib as First-line and Maintenance Therapy for Newly Diagnosed High-risk Ovarian Cancer
NCT06437353Ovarian Cancer
Anhui Provincial Cancer Hospital
Phase 2
74
Hefei
2024-05-25
Recruiting
A Study of GLB-001 in Patients With Myeloid Malignancies
NCT06378437Polycythemia Vera, Essential Thrombocythemia, Myelofibrosis, Myelodysplastic Syndromes
Hangzhou GluBio Pharmaceutical Co., Ltd.
Phase 1
108
Hefei, Beijing, Chongqing, Shijiazhuang, Zhengzhou, Wuhan, Suzhou, Nanchang
2024-05-24
Recruiting
Fruquintinib With or Without HAI-FOLFOX for Refractory Colorectal Cancer
NCT06441565Colorectal Cancer
Sun Yat-sen University
Phase 2/3
84
Guangzhou
2024-05-24
Recruiting
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
NCT06375044Relapsed or Refractory Multiple Myeloma
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
130
Beijing, Fuzhou, Guangzhou, Zhengzhou, Nanjing, Tianjin, Hanzhou
2024-05-24
Recruiting
Efficacy and Safety of Ganciclovir Capsules in the Treatment of Refractory Moderate-to-severe Allergic Rhinitis
NCT06436534Rhinitis, Allergic
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
50
Wuhan
2024-05-24
Recruiting
Immunotherapy Rechallenge in Patients with Solid Tumors in Clinical Trials
NCT06612632Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1/2
100
Beijing
2024-05-24
Active, closed
Durvalumab Combined With S-1 as Adjuvant Therapy of Resectable BTC
NCT06490107Biliary Tract Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
40
Beijing
2024-05-24
Recruiting
Safety and Efficacy of PRG-2302 for Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia Disease.
NCT06659653Acute Lymphoblastic Leukemia
Tan Jie
Phase EARLY_PHASE1
18
Jinzhou
2024-05-24
Recruiting
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) โ‰ฅ50% (MK-1084-004/KANDLELIT-004)
NCT06345729Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC
Phase 3
600
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Harbin, Jiamusi
2024-05-24
Recruiting
MRD Response-adapted Allo-HSCT for Adverse-risk AML
NCT06301425Acute Myeloid Leukemia
Peking University People's Hospital
Not applicable
178
Beijing
2024-05-24
Recruiting
Clinical Exploration Trial of YOLT-101 in the Treatment of Familial Hypercholesterolemia (FH)
NCT06458010Familial Hypercholesterolemia
RenJi Hospital
Phase EARLY_PHASE1
20
Shanghai
2024-05-24
Recruiting
Impact of External Drainage of the Main Pancreatic Duct and Common Bile Duct on Pancreatic Fistula Following Pancreaticoduodenectomy
NCT06322680Pancreaticoduodenectomy
Shanghai Zhongshan Hospital
Not applicable
322
Shanghai
2024-05-24
Recruiting
A Multicenter, Prospective, Phase II Study of Zanubrutinib for Maintenance in Patients With Mantle Cell Lymphoma
NCT06341556Mantle Cell Lymphoma, Maintenance Therapy
Fudan University
Phase 2
52
Shanghai
2024-05-24
Recruiting
A Study of GQ1010 in Subjects With Advanced Solid Tumors
NCT06464055Advanced Malignant Solid Tumors
GeneQuantum Healthcare (Suzhou) Co., Ltd.
Phase 1/2
260
Beijing, Harbin, Tianjin, Wuhan, Zhengzhou
2024-05-23
Recruiting
A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Diffuse Large B-Cell Lymphoma Patients
NCT06569485DLBCL
Sun Yat-sen University
Phase 2
38
Guangzhou
2024-05-23
Recruiting
Clinical Effects of Keratinized Mucosa Augmentation Around Dental Implant With Free Gingival Graft in Different Surgical Timing at Mandibular Posterior Sites
NCT07088172Edentulous Alveolar Ridge In Mandible
The Dental Hospital of Zhejiang University School of Medicine
Not applicable
24
Hangzhou
2024-05-23
Recruiting
The Effect of Different Body Positions and Channel Sheaths on RIRS
NCT06438497Urolithiasis
The First Affiliated Hospital of Guangzhou Medical University
Not applicable
120
Guangzhou
2024-05-23
Active, closed
A Study Comparing BL-B01D1 With Platinum Based Chemotherapy in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer(PANKU-Lung01)
NCT06382116Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
432
Guangzhou
2024-05-22
Active, closed
Irinotecan Liposomes in Combination With Nituzumab for the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of First-Line or Higher Immunotherapy
NCT06414577Nasopharyngeal Cancer
XIANG YANQUN
Phase 2
38
Guangzhou
2024-05-22
Recruiting
Study of Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Limited-stage Small Cell Lung Cancer (LS-SCLC)
NCT06911606SCLC, Limited Stage
Guangdong Provincial People's Hospital
Phase 2
45
Guangzhou
2024-05-22
Recruiting
Spectral CT in Radiotherapy for Cervical Cancer
NCT06433817Cervical Cancer, Radiotherapy
Peking Union Medical College Hospital
Observational
150
Beijing
2024-05-22
Recruiting
Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer or Pulmonary Oligometastases
NCT06542159Adaptive Radiotherapy, Stereotactic Body Radiotherapy, Non-small Cell Lung Cancer, Lung Oligometastases
Sun Yat-sen University
Phase 2
130
Guangzhou
2024-05-22
Recruiting
Perioperative Treatment of Resectable Adenocarcinoma of Esophagogastric Junction by Immunotherapy (Adebrelimab) Combined With Chemotherapy (XELOX): a Prospective, Single-center, Feasibility Study
NCT06482788Esophagogastric Junction Adenocarcinoma
Ruijin Hospital
Phase 2
26
Shanghai
2024-05-22
Not yet open
A Phase II Study of Surufatinib Combined With Camrelizumab and mFOLFOX6 as Second-line Treatment for Advanced PRAD
NCT06329947Advanced Pancreatic Cancer
Rui-hua Xu, MD, PhD
Phase 2
37
Guangzhou
2024-05-22
Recruiting
Study of AU409 Capsule in Advanced Hepatocellular Carcinoma Patients Who Failed Standard Treatment
NCT06374485Advanced Hepatocellular Carcinoma
Lee's Pharmaceutical Limited
Phase 1
18
Hong Kong
2024-05-21
Recruiting
Intra- and Interindividual Moderators of Prefrontal Excitability Investigated Using Simultaneous TMS With Neuroimaging
NCT06976879Healthy Adults
The Hong Kong Polytechnic University
Observational
60
Hong Kong
2024-05-21
Recruiting
Clinical Study of HIFU for Localized Prostate Cancer
NCT06362577Localized Prostate Cancer
RenJi Hospital
Observational
60
Shanghai
2024-05-21
Recruiting
ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chronic Hepatitis B Virus Infection
NCT07573943Chronic Hepatitis b
The Second Affiliated Hospital of Chongqing Medical University
Phase 4
120
Chongqing
2024-05-21
Recruiting
Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic Leukemia
NCT06607419B-Cell Lymphoblastic Leukemia
Shanghai Jiao Tong University School of Medicine
Phase 2/3
90
Hefei, Fuzhou, Shanghai, Ningbo
2024-05-21
Recruiting
A Study of Bupivacaine Liposome Injection in Local Analgesia of Pediatric Patients
NCT06344091Local Analgesia Via Infiltration
Jiangsu HengRui Medicine Co., Ltd.
Phase 4
232
Guangzhou
2024-05-21
Recruiting
Acupuncture of Different Treatment Frequency in Chronic Plantar Fasciitis
NCT06284993Plantar Fasciitis, Chronic
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Not applicable
80
Beijing
2024-05-21
Recruiting
Using the Chinese Indigenization FS Scale in the Diagnosis of Fibromyalgia๏ผš Specificity and Sensitivity in Clinical Practice
NCT06533410Fibromyalgia
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Observational
59
Beijing
2024-05-21
Recruiting
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
NCT06133972Systemic Lupus Erythematosus
Novartis Pharmaceuticals
Phase 3
550
Guangzhou, Shantou, Nanjing, Suzhou, Nanchang, Pingxiang, Changchun, Linyi
2024-05-21
Recruiting
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
NCT06203210Small Cell Lung Cancer
Daiichi Sankyo
Phase 3
540
Beijing, Changchun, Changsha, Chengdu, Chongqing, Haerbin, Hangzhou, Jiangxi
2024-05-21
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
NCT06237452Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence, Clostridioides Difficile Infection
Vedanta Biosciences, Inc.
Phase 3
852
2024-05-20
By invitation
A Study Comparing Degu Insulin Liraglutide Injection With Premixed Insulin on the Prognosis of Diabetes Mellitus
NCT06925334Type 2 Diabetic Patients
Beijing Tsinghua Chang Gung Hospital
Phase 4
170
Beijing
2024-05-20
Recruiting
Artificial Intelligence-assisted System in Colonoscopy
NCT06406062Adenoma Colon Polyp
Renmin Hospital of Wuhan University
Observational
7,500
Wuhan
2024-05-20
Recruiting
Sources and Mechanisms of Energy Compensation
NCT06432517Energy Expenditure, Exercise, Energy Intake, Food Preferences
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Not applicable
81
Shenzhen
2024-05-20
Not yet open
Evaluation of the Efficacy and Safety of Indocyanine Green Tracing in 3D Fluorescent Laparoscopic Lymph Node Dissection for Gastric Cancer
NCT06421220Gastric Cancer
Qilu Hospital of Shandong University
Not applicable
484
Jinan
2024-05-20
Recruiting
Efficacy and Safety of Clascoterone Cream 1% in Facial Acne Vulgaris
NCT06403501Acne Vulgaris
Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.
Phase 3
692
Shanghai
2024-05-20
Recruiting
Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)
NCT06353386Prostatic Neoplasms, Castration-Resistant
Merck Sharp & Dohme LLC
Phase 1/2
220
2024-05-20
Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
NCT06307665Asthma
AstraZeneca
Phase 3
440
Beijing, Bengbu, Chengdu, Chongqing, Hohhot, Mianyang, Shanghai, Shantou
2024-05-20
Recruiting
99mTc-QULIC-5-P1 SPECT Imaging in Patients With Prostate Cancer
NCT06419348Prostate Cancer Stage, PSMA, SPECT
First Affiliated Hospital of Chongqing Medical University
Phase EARLY_PHASE1
30
Chongqing
2024-05-20
Recruiting
bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC
NCT06061276Liver Diseases, Hepatocellular Carcinoma, Immunotherapy, Camrelizumab
Sun Yat-sen University
Not applicable
40
Guanzhou
2024-05-20
Recruiting
IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes
NCT06118840Intracranial Aneurysm, CT Angiography, Deep Learning, Double Bind Interaction
Jinling Hospital, China
Not applicable
6,450
Hefei, Wuhu, Guiyang, Zhengzhou, Shiyan, Nanjing, Xuzhou, Changchun
2024-05-20
Recruiting
Predictive Effect of TGF-ฮฒ and INS-PI3K-AKT Related Proteins for POD in Diabetes Patients
NCT06426953Diabetes, Postoperative Delirium
Xie Kangjie
Observational
180
Duyun, Hangzhou
2024-05-20
Recruiting
Pelvic Floor Rehabilitation of Female Pelvic Floor Dysfunction
NCT06461234Pelvic Floor Disorders, Pelvic Organ Prolapse
Mingfu Wu
Observational
1,360
Wuhan
2024-05-20
Recruiting
Sintilimab, Pegaspargase Plus GemOx for Untreated Extranodal NK/T-Cell Lymphoma
NCT06824883Extranodal NK/T-cell Lymphoma
Peking Union Medical College Hospital
Phase 2
49
Beijing
2024-05-20
Recruiting
68Ga-PSFA PET Imaging in Patients With PSMA/FAP Positive Disease
NCT06387381PSMA, FAP, Positron-Emission Tomography
First Affiliated Hospital of Chongqing Medical University
Phase EARLY_PHASE1
30
Chongqing
2024-05-20
Recruiting
County Medical Community-based, Cardiovascular Risk Stratified Integrated Care Model: a Pragmatic Cluster Randomised Control Trial
NCT06302127Hypertension, Diabetes Mellitus Type 2, Cardiovascular Diseases
Peking University
Not applicable
2,560
Sanming, Liuzhou
2024-05-20
By invitation
A Randomized Controlled Trial of the "Psychological Training Camp & Obstetrician-Led Psychoprenatal Intervention (PICONI)" Stepwise Intervention Model for Depression and Anxiety During Pregnancy.
NCT06383221Perinatal Depression, Stepped Care, Perinatal Anxiety
Fangbiao Tao
Not applicable
600
Maโ€™anshan
2024-05-20
Recruiting
A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC
NCT06424899Non Small Cell Lung Cancer
Zeng Jian
Phase 2
92
Hangzhou
2024-05-19
Active, closed
A Study to Evaluate ANS014004 in Subjects With Locally Advanced or Metastatic Solid Tumors
NCT06328439Locally Advanced or Metastatic Solid Tumors
Avistone Biotechnology Co., Ltd.
Phase 1
40
Shanghai
2024-05-19
Recruiting
A Study of Paclitaxel Combined With Apatinib and Adebrelimab in Gastric/Gastroesophageal Junction Adenocarcinoma
NCT06415669Gastric/Gastroesophageal Junction Adenocarcinoma
The First Affiliated Hospital of Xiamen University
Phase 2
30
Fuzhou
2024-05-19
Active, closed
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma
NCT06158841Multiple Myeloma
AbbVie
Phase 3
421
Beijing, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Nanjing, Suzhou, Nanchang
2024-05-19
Active, closed
A Study Comparing BL-B01D1 With Docetaxel in Patients With Unresectable Locally Advanced or Metastatic EGFR Wild-type Non-small Cell Lung Cancer(PANKU-Lung02)
NCT06382129Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
698
Beijing
2024-05-17
By invitation
Protocol for Evaluating Physiological and Psychological Adaptation Mechanisms in Tibetan Plateau Environments
NCT06557928High Altitude
Peking Union Medical College Hospital
Observational
17
Beijing
2024-05-17
Active, closed
The Treatment of PD-1 Antibody Combined With Peg-IFNฮฑ in NAs-suppressed CHB Patients
NCT06357806Chronic Hepatitis B
Beijing 302 Hospital
Not applicable
45
Beijing
2024-05-17
Recruiting
Online Adaptive Radiotherapy for Nasopharyngeal Carcinoma
NCT06516133Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3
494
Guangzhou
2024-05-17
Recruiting
Screening of Biomarkers and Related Mechanisms for RIX
NCT07170358Xerostomia Due to Radiotherapy (Disorder)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
50
Nanjing, Hangzhou
2024-05-17
Recruiting
A Prospective, Single-arm, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Tafolecimab and Sintilimab Combined With Chemotherapy in Patients With Advanced or Metastatic Driver Gene-negative Non-small Cell Lung Cancer After Failure of First-line Immunotherapy.
NCT06421298Lung Cancer
Jinghui Wang
Phase 2
30
Beijing
2024-05-17
Recruiting
Genetic Markers of Diabetic Ulcers and Personalized Treatment Targets Research
NCT06979037Diabetic Ulcers
The First Affiliated Hospital of University of South China
Observational
712
Hengyang
2024-05-16
Active, closed
Phase 1b/2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC
NCT06477523SCLC, Extensive Stage
Sichuan University
Phase 1/2
57
Chengdu
2024-05-16
Recruiting
Fluorouracil Treatment Via Colon for Colorectal Cancer
NCT06385418Colorectal Cancer
The Second Hospital of Nanjing Medical University
Phase 2
40
Nanjing
2024-05-16
Recruiting
RC48 Treatment for Platinum Sensitive Recurrent Ovarian Cancer With HER2 Expression
NCT06420973Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma
Peking University Cancer Hospital & Institute
Phase 2
54
Beijing
2024-05-16
Recruiting
GDFT on the Postoperative Outcome in Head and Neck Cancer Surgery
NCT06468852Postoperative Complications
Beijing Tongren Hospital
Not applicable
340
Beijing
2024-05-16
Recruiting
Radiotherapy to Patients With CA19-9-elevated Advanced Pancreatic Cancer
NCT06250972Pancreatic Adenocarcinoma
Fudan University
Phase 3
210
Shanghai
2024-05-15
Recruiting
A Study of MT027 in Patients with Pleural Malignant Tumors
NCT06726564Advanced Malignant Solid Tumor, Malignant Pleural Effusion, Pleura Carcinoma, Pleural Mesothelioma
Suzhou Maximum Bio-tech Co., Ltd.
Phase 1
18
Beijing
2024-05-15
Rows per page Showing 12701–12800 of 19052
Previous 126 127 128 129 130 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=128

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.